Free Trial

Alcon Q4 2023 Earnings Report

Alcon logo
$87.84 +0.50 (+0.57%)
(As of 12/4/2024 ET)

Alcon EPS Results

Actual EPS
$0.70
Consensus EPS
$0.68
Beat/Miss
Beat by +$0.02
One Year Ago EPS
$0.42

Alcon Revenue Results

Actual Revenue
$2.33 billion
Expected Revenue
$2.34 billion
Beat/Miss
Missed by -$7.59 million
YoY Revenue Growth
+8.20%

Alcon Announcement Details

Quarter
Q4 2023
Time
After Market Closes
Strange: Why is Amazon suddenly yielding 39.70%? (Ad)

Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%!

Click here to see this breakthrough before everyone else →

Alcon Earnings Headlines

Alcon Inc. (ALC): A Bull Case Theory
Strange: Why is Amazon suddenly yielding 39.70%?
Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%!
See More Alcon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alcon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alcon and other key companies, straight to your email.

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

View Alcon Profile

More Earnings Resources from MarketBeat